Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 19:12:963617.
doi: 10.3389/fonc.2022.963617. eCollection 2022.

The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression

Lu Xia  1 , Jingyun Chen  1 , Min Huang  1 , Jie Mei  1 , Min Lin  1
Affiliations
Review

The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression

Lu Xia et al. Front Oncol. .

Abstract

Accumulated evidence has revealed that F-box protein, a subunit of SCF E3 ubiquitin ligase complexes, participates in carcinogenesis and tumor progression via targeting its substrates for ubiquitination and degradation. F-box proteins could be regulated by cellular signaling pathways and noncoding RNAs in tumorigenesis. Long noncoding RNA (lncRNA), one type of noncoding RNAs, has been identified to modulate the expression of F-box proteins and contribute to oncogenesis. In this review, we summarize the role and mechanisms of multiple lncRNAs in regulating F-box proteins in tumorigenesis, including lncRNAs SLC7A11-AS1, MT1JP, TUG1, FER1L4, TTN-AS1, CASC2, MALAT1, TINCR, PCGEM1, linc01436, linc00494, GATA6-AS1, and ODIR1. Moreover, we discuss that targeting these lncRNAs could be helpful for treating cancer via modulating F-box protein expression. We hope our review can stimulate the research on exploration of molecular insight into how F-box proteins are governed in carcinogenesis. Therefore, modulation of lncRNAs is a potential therapeutic strategy for cancer therapy via regulation of F-box proteins.

Keywords: F-box protein; cancer; lncRNAs; noncoding RNA; oncogenesis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Multiple lncRNAs regulate the expression of FBXW7 in human cancer. Multiple lncRNAs, including MT1JP, FER1L4, TTN-AS1, CASC2 and MALAT1, have been demonstrated to regulate the expression of FBXW7 in tumorigenesis.
Figure 2
Figure 2
Multiple lncRNAs regulate the expression of F-box proteins in human cancer. Multiple lncRNAs, including SLC7A11-AS1, MALAT1, PCGEM1, linc01436, linc00494 and GATA6-AS1, regulate the expression of several F-box proteins in tumorigenesis.
See this image and copyright information in PMC

References

    1. Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by f-box proteins. Nat Rev Mol Cell Biol (2013) 14:369–81. doi: 10.1038/nrm3582 - DOI - PMC - PubMed
    1. Zheng N, Zhou Q, Wang Z, Wei W. Recent advances in SCF ubiquitin ligase complex: clinical implications. Biochim Biophys Acta (2016) 1866:12–22. doi: 10.1016/j.bbcan.2016.05.001 - DOI - PMC - PubMed
    1. Wang Z, Liu P, Inuzuka H, Wei W. Roles of f-box proteins in cancer. Nat Rev Cancer (2014) 14:233–47. doi: 10.1038/nrc3700 - DOI - PMC - PubMed
    1. Liu J, Chen T, Li S, Liu W, Wang P, Shang G. Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy. Semin Cancer Biol Ahead Print (2022) S1044–579X(22):00138–9. doi: 10.1016/j.semcancer.2022.06.004 - DOI - PubMed
    1. Gao J, Yang D, Cao R, Huang H, Ma J, Wang Z, et al. The role of Fbxo5 in the development of human malignant tumors. Am J Cancer Res (2022) 12:1456–64. - PMC - PubMed

LinkOut - more resources